The global Lung Cancer Diagnostics market was valued at US$ 1938 million in 2022 and is projected to reach US$ 2805.4 million by 2029, at a CAGR of 5.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
This report aims to provide a comprehensive presentation of the global market for Lung Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Diagnostics. This report contains market size and forecasts of Lung Cancer Diagnostics in global, including the following market information:
- Global Lung Cancer Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
As people's awareness of cancer increases and technology advances, as well as private and government support, these are some of the factors that are expected to drive market growth.
We surveyed the Lung Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Lung Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other
Global Lung Cancer Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Lung Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
Industrial
Healthcare
Other
Global Lung Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Lung Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Lung Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
BioM?rieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic
HalioDx SAS
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lung Cancer Diagnostics, market overview.
Chapter 2: Global Lung Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Lung Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lung Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Diagnostics Overall Market Size
2.1 Global Lung Cancer Diagnostics Market Size: 2022 VS 2030
2.2 Global Lung Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Diagnostics Players in Global Market
3.2 Top Global Lung Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Lung Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lung Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Diagnostics Market Size Markets, 2022 & 2030
4.1.2 Immunoassays
4.1.3 Flow Cytometry
4.1.4 Rapid Tests
4.1.5 Molecular Assays
4.1.6 Tissue Arrays
4.1.7 Circulating Tumor Cells
4.1.8 Pharmacodiagnostics
4.1.9 Biomarkers
4.1.10 Other
4.2 By Type - Global Lung Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Lung Cancer Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Diagnostics Market Size, 2022 & 2030
5.1.2 Industrial
5.1.3 Healthcare
5.1.4 Other
5.2 By Application - Global Lung Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Lung Cancer Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Lung Cancer Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Lung Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Lung Cancer Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Lung Cancer Diagnostics Revenue, 2018-2030
6.3.2 US Lung Cancer Diagnostics Market Size, 2018-2030
6.3.3 Canada Lung Cancer Diagnostics Market Size, 2018-2030
6.3.4 Mexico Lung Cancer Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Diagnostics Revenue, 2018-2030
6.4.2 Germany Lung Cancer Diagnostics Market Size, 2018-2030
6.4.3 France Lung Cancer Diagnostics Market Size, 2018-2030
6.4.4 U.K. Lung Cancer Diagnostics Market Size, 2018-2030
6.4.5 Italy Lung Cancer Diagnostics Market Size, 2018-2030
6.4.6 Russia Lung Cancer Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Lung Cancer Diagnostics Market Size, 2018-2030
6.4.8 Benelux Lung Cancer Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Diagnostics Revenue, 2018-2030
6.5.2 China Lung Cancer Diagnostics Market Size, 2018-2030
6.5.3 Japan Lung Cancer Diagnostics Market Size, 2018-2030
6.5.4 South Korea Lung Cancer Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Lung Cancer Diagnostics Market Size, 2018-2030
6.5.6 India Lung Cancer Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Lung Cancer Diagnostics Revenue, 2018-2030
6.6.2 Brazil Lung Cancer Diagnostics Market Size, 2018-2030
6.6.3 Argentina Lung Cancer Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Diagnostics Revenue, 2018-2030
6.7.2 Turkey Lung Cancer Diagnostics Market Size, 2018-2030
6.7.3 Israel Lung Cancer Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Lung Cancer Diagnostics Market Size, 2018-2030
6.7.5 UAE Lung Cancer Diagnostics Market Size, 2018-2030
7 Lung Cancer Diagnostics Companies Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Company Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Lung Cancer Diagnostics Major Product Offerings
7.1.4 Roche Diagnostics Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Roche Diagnostics Key News & Latest Developments
7.2 BioM?rieux
7.2.1 BioM?rieux Company Summary
7.2.2 BioM?rieux Business Overview
7.2.3 BioM?rieux Lung Cancer Diagnostics Major Product Offerings
7.2.4 BioM?rieux Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 BioM?rieux Key News & Latest Developments
7.3 Qiagen
7.3.1 Qiagen Company Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Lung Cancer Diagnostics Major Product Offerings
7.3.4 Qiagen Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Qiagen Key News & Latest Developments
7.4 Advpharma
7.4.1 Advpharma Company Summary
7.4.2 Advpharma Business Overview
7.4.3 Advpharma Lung Cancer Diagnostics Major Product Offerings
7.4.4 Advpharma Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Advpharma Key News & Latest Developments
7.5 AIT Austrian Institute of Technology
7.5.1 AIT Austrian Institute of Technology Company Summary
7.5.2 AIT Austrian Institute of Technology Business Overview
7.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Major Product Offerings
7.5.4 AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 AIT Austrian Institute of Technology Key News & Latest Developments
7.6 Courtagen Life Sciences
7.6.1 Courtagen Life Sciences Company Summary
7.6.2 Courtagen Life Sciences Business Overview
7.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Major Product Offerings
7.6.4 Courtagen Life Sciences Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Courtagen Life Sciences Key News & Latest Developments
7.7 DiagnoCure
7.7.1 DiagnoCure Company Summary
7.7.2 DiagnoCure Business Overview
7.7.3 DiagnoCure Lung Cancer Diagnostics Major Product Offerings
7.7.4 DiagnoCure Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 DiagnoCure Key News & Latest Developments
7.8 BioMark Diagnostics
7.8.1 BioMark Diagnostics Company Summary
7.8.2 BioMark Diagnostics Business Overview
7.8.3 BioMark Diagnostics Lung Cancer Diagnostics Major Product Offerings
7.8.4 BioMark Diagnostics Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 BioMark Diagnostics Key News & Latest Developments
7.9 Mayo Clinic
7.9.1 Mayo Clinic Company Summary
7.9.2 Mayo Clinic Business Overview
7.9.3 Mayo Clinic Lung Cancer Diagnostics Major Product Offerings
7.9.4 Mayo Clinic Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Mayo Clinic Key News & Latest Developments
7.10 HalioDx SAS
7.10.1 HalioDx SAS Company Summary
7.10.2 HalioDx SAS Business Overview
7.10.3 HalioDx SAS Lung Cancer Diagnostics Major Product Offerings
7.10.4 HalioDx SAS Lung Cancer Diagnostics Revenue in Global Market (2018-2023)
7.10.5 HalioDx SAS Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lung Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Diagnostics Market Drivers in Global Market
Table 3. Lung Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Diagnostics in Global Market
Table 5. Top Lung Cancer Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Lung Cancer Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Lung Cancer Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Lung Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Lung Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Lung Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Lung Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Lung Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Lung Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Lung Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Lung Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Lung Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Lung Cancer Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Lung Cancer Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Lung Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Lung Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Lung Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Lung Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Lung Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Roche Diagnostics Company Summary
Table 31. Roche Diagnostics Lung Cancer Diagnostics Product Offerings
Table 32. Roche Diagnostics Lung Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Diagnostics Key News & Latest Developments
Table 34. BioM?rieux Company Summary
Table 35. BioM?rieux Lung Cancer Diagnostics Product Offerings
Table 36. BioM?rieux Lung Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. BioM?rieux Key News & Latest Developments
Table 38. Qiagen Company Summary
Table 39. Qiagen Lung Cancer Diagnostics Product Offerings
Table 40. Qiagen Lung Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Qiagen Key News & Latest Developments
Table 42. Advpharma Company Summary
Table 43. Advpharma Lung Cancer Diagnostics Product Offerings
Table 44. Advpharma Lung Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Advpharma Key News & Latest Developments
Table 46. AIT Austrian Institute of Technology Company Summary
Table 47. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Offerings
Table 48. AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. AIT Austrian Institute of Technology Key News & Latest Developments
Table 50. Courtagen Life Sciences Company Summary
Table 51. Courtagen Life Sciences Lung Cancer Diagnostics Product Offerings
Table 52. Courtagen Life Sciences Lung Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Courtagen Life Sciences Key News & Latest Developments
Table 54. DiagnoCure Company Summary
Table 55. DiagnoCure Lung Cancer Diagnostics Product Offerings
Table 56. DiagnoCure Lung Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. DiagnoCure Key News & Latest Developments
Table 58. BioMark Diagnostics Company Summary
Table 59. BioMark Diagnostics Lung Cancer Diagnostics Product Offerings
Table 60. BioMark Diagnostics Lung Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. BioMark Diagnostics Key News & Latest Developments
Table 62. Mayo Clinic Company Summary
Table 63. Mayo Clinic Lung Cancer Diagnostics Product Offerings
Table 64. Mayo Clinic Lung Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Mayo Clinic Key News & Latest Developments
Table 66. HalioDx SAS Company Summary
Table 67. HalioDx SAS Lung Cancer Diagnostics Product Offerings
Table 68. HalioDx SAS Lung Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. HalioDx SAS Key News & Latest Developments
List of Figures
Figure 1. Lung Cancer Diagnostics Segment by Type in 2022
Figure 2. Lung Cancer Diagnostics Segment by Application in 2022
Figure 3. Global Lung Cancer Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Lung Cancer Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Diagnostics Revenue in 2022
Figure 8. By Type - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Lung Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Lung Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Lung Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Lung Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Lung Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Lung Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Lung Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Lung Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Lung Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Roche Diagnostics Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BioM?rieux Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Qiagen Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Advpharma Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Courtagen Life Sciences Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. DiagnoCure Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. BioMark Diagnostics Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Mayo Clinic Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. HalioDx SAS Lung Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
